CoChat

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus

Malek, Rana, Davis, Stephen N. · 2016 · Expert Opinion on Drug Metabolism & Toxicology

Abstract

INTRODUCTION: Gestational diabetes mellitus (GDM) complicates 10% of all pregnancies and is defined as hyperglycemia first noted during pregnancy. Rates of GDM are rising and untreated GDM results in complications for both mother and fetus. GDM is often managed by diet and exercise but 30-40% of women will require pharmacological intervention. Insulin has traditionally been the treatment of choice but since 2007, glyburide, a second generation sulfonylurea has become the most prescribed medication for GDM. AREAS COVERED: This review will cover the pharmacokinetics, efficacy, and safety of glyburide for the management of GDM. EXPERT OPINION: Management of GDM is challenging secondary to the stringent glycemic goals that mimic the lower glucose levels in pregnancy. Glyburide is generally effective in treating hyperglycemia. However, several studies have raised safety concerns showing higher neonatal intensive care unit (NICU) admissions, higher rates of macrosomia, large for gestational age and pre-eclampsia in the mother. For this reason, insulin should be first-line therapy for GDM. In areas of limited resources where the self-monitoring needed for accurate insulin dosing is not possible, where access to refrigeration for insulin storage is not universal, or severe needle phobia then the benefits of glyburide (controlling hyperglycemia) outweighs the harm of NICU admissions and macrosomia.

Overview

Integrity signals

Registry

Crossref · 10.1080/17425255.2016.1187131

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Research works printed but not linked: 2

  1. Maliepaard M, 2001, Cancer Res, 61, 3458
  2. Mirzamoradi M, 2015, Acta Med Iran, 53, 97

Cited by

See all 54

Metadata

Authors
Malek, R., & Davis, S. N.
Affiliations
  • University of Maryland, Baltimore (US)
  • University of Maryland Medical Center (US)
Corresponding author
Davis, Stephen N.
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2016-05-23
Volume
12
Issue
6
Pages
691-699
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W2362195380
Cited by
54
References
50
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 10 · 2019: 3 · 2018: 6 · 2017: 2
FWCI
0.65
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
glibenclamide, gestational diabetes mellitus, sulfonylureas, pharmacokinetics, drug safety, glycemic control, neonatal intensive care admission, macrosomia, preeclampsia, insulin therapy, antidiabetic drugs
MeSH terms
Animals, Blood Glucose, Female, Glyburide, Humans, Hypoglycemic Agents, Infant, Newborn, Insulin, Intensive Care Units, Neonatal, Pregnancy, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. https://app.cochat.ai/papers/10.1080/17425255.2016.1187131
The paper
Malek, R., & Davis, S. N. (2016). Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2016.1187131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.